Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates

Assertio (ASRT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -70.00%. A quarter ago, it was expected that this drugmaker would post a loss of $0.06 per share when it actually produced a loss of $0.14, delivering a surprise of -133.33%.Over the last four quarters, the company has surpassed ...